National Intranasal Booster Doses Against Covid-19 Are Easy To Administer | What Are These? BY Outlook News Desk
National Bharat Biotech's Intranasal Booster Dose Gets DCGI's Approval For Phase-3 Trials BY Outlook News Desk
National No Paracetamol, Painkillers Recommended After Covaxin Jab: Bharat Biotech BY Outlook News Desk
National Covid-19 Vaccine For Teenagers: DCGI Grants Emergency Authorisation To Covaxin BY Outlook News Desk
National Bharat Biotech Seeks Trial For Phase-3 Intranasal Covid-19 Booster Dose BY Outlook News Desk
Business The Jab Of Life: Covaxin’s Success Proves Bharat Biotech Was On Right Path BY Outlook News Desk
National Bharat Biotech’s US Partner Seeks Approval For Use Of Covaxin In Children BY Outlook News Desk
National Covaxin Gets WHO Nod For Emergency Use: What That Means For Indian Travelers BY Outlook News Desk
National WHO Negotiates With Bharat Biotech To Join UN Agency's Tech Access Pool BY Outlook News Desk
National Covaxin: WHO Panel Recommends Emergency Use Listing Status For Bharat Biotech's Covid Vaccine BY Outlook News Desk
National Covaxin: Bharat Biotech's Covid-19 Shot Gets Shelf Life Extension Up To 12 Months BY Outlook News Desk
National Australia Recognises Covaxin: All Countries That Have Approved Bharat Biotech's Covid-19 Vaccine BY Outlook News Desk
National Covaxin: 7 Countries Allowing Entry To Indians Vaccinated With Bharat Biotech's Covid-19 Shot BY Outlook News Desk
Making A Difference Covid-19 Vaccine: Oman Approves Bharat Biotech's Covaxin Under New Travel Rules BY Outlook News Desk
National WHO Technical Group To Meet On Oct 26 To Consider EUL Of Bharat Biotech’s Covaxin BY Outlook News Desk
National Bharat Biotech's New Plant Dispatches First Commercial Batch Of Covaxin BY Outlook News Desk
National Revised Covishield Monthly Production Likely To be More Than 120 Million, Covaxin 58 Million: Health Minister BY Outlook News Desk
National Govt Expects 4 More Indian Pharma Brands To Begin Vaccine Production By Oct-Nov: Health Minister BY Outlook News Desk
National Covaxin Provides Protection Against Delta Plus Covid Variant: ICMR Study BY Outlook Web Bureau
Making A Difference Brazil Suspends Covaxin’s Clinical Trials After Bharat Biotech Ends Deal With Precisa Medicamentos BY Outlook Web Bureau
.jpg?auto=format%2Ccompress&fit=max&format=webp&w=300&dpr=1.0)
